← Association for Accessible Medicines
FDANonrulemakingFDA-2021-D-1031

Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act; Draft Guidance for Industry; Availability

RIN
—
Last modified
Feb 6, 2024
Comment window
closed 1667d ago
Association for Accessible Medicines filings
2

Activity

Association for Accessible Medicines filed 2 comments on this docket between Dec 30, 2021 and Apr 29, 2022. 3 other organizations filed here. The comment window closed 1667d ago.

What Association for Accessible Medicines filed (2)

Apr 29, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2021-D-1031-0028

Comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2021-D-1031:Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act.

View on regulations.gov →
Dec 30, 2021· Comment from Association for Accessible Medicines (AAM)· FDA-2021-D-1031-0015

Comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2021-D-1031:Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (3)

See everyone who commented →